About
ACTC infrastructure includes expertise in study design and conduct, and full clinical trial management capability through our coordinating center and network of trial sites.
Projects
We collaborate with investigators to develop and implement projects addressing all ranges of disease, from preclinical to end stages, and through a variety of mechanisms.
Member Sites
Member Sites represent the top experts in the field at academic centers across the US, and guide ACTC through the Steering Committee and other committees.
What is Alzheimer’s?
Alzheimer’s disease is an irreversible, progressive brain disorder that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks. In most people with the disease—those with the late-onset type—symptoms first appear in their mid-60s. Early-onset Alzheimer’s occurs between a person’s 30s and mid-60s and is very rare. Alzheimer’s disease is the most common cause of dementia among older adults.
New Training Course
IMPACT-AD is an Alzheimer’s Disease and related disorders (ADRD) course that aims to educate and promote diversity among investigative staff members and future principal investigators in the field of Alzheimer’s research.
Now accepting applications!
